OverviewChartNewsTraderScreen

BNP Paribas Knock-Out PGR/  DE000PC477B8  /

Frankfurt Zert./BNP
02/08/2024  21:50:31 Chg.+0.070 Bid21:59:52 Ask21:59:52 Underlying Strike price Expiration date Option type
3.150EUR +2.27% 3.200
Bid Size: 1,259		 3.210
Ask Size: 1,259		 Progressive Corporat... 187.8572 USD 31/12/2078 Call
TeleTrader 29/07 Putin congratulates Maduro on election victory
TeleTrader 27/07 G20 agrees to work together to tax billionaires
TeleTrader 25/07 Nikki Haley not surprised by Biden's presidential race exit
TeleTrader 15/07 Syrians head to polls for parliamentary elections
TeleTrader 13/07 Progressive Caucus meets with Biden
TeleTrader 11/07 Peskov: NATO nears Russia's borders, could provoke response
TeleTrader 08/07 Lula proud of France's fight against 'extremism'
TeleTrader 05/07 Trudeau, Albanese welcome Labour Party's landslide victory
GlobeNewswire 25/06 argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 P...
GlobeNewswire 25/06 AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial
GlobeNewswire 24/06 Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Tri...
GlobeNewswire 24/06 4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...
GlobeNewswire 24/06 Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-4...
GlobeNewswire 19/06 Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens
GlobeNewswire 18/06 Afamelanotide in fair-skinned Parkinson’s patients
GlobeNewswire 14/06 Progressive Reports May 2024 Results
GlobeNewswire 13/06 Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...
GlobeNewswire 12/06 Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...
GlobeNewswire 12/06 Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire 11/06 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire 11/06 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...
GlobeNewswire 11/06 FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclero...
GlobeNewswire 10/06 LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...
GlobeNewswire 10/06 SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...
TeleTrader 09/06 EP updated results, EPP with 189 seats